| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Rosalinda Guevara-Guzmán | |
| Octavio Mercado-Gómez | |||
| Jorge Landgrave-Gómez | |||
| P2860 | cites work | A two-stage meta-analysis identifies several new loci for Parkinson's disease | Q21144948 |
| Long-term outcomes of children treated with the ketogenic diet in the past | Q43173500 | ||
| Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models | Q43187683 | ||
| Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing | Q44915813 | ||
| Differential upregulation of extracellular matrix molecules associated with the appearance of granule cell dispersion and mossy fiber sprouting during epileptogenesis in a murine model of temporal lobe epilepsy | Q45121746 | ||
| Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. | Q45922651 | ||
| Physiology. When metabolism and epigenetics converge. | Q45997632 | ||
| Connecting threads: epigenetics and metabolism | Q46493363 | ||
| Nuclear localization of alpha-synuclein and its interaction with histones | Q46597702 | ||
| Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats. | Q46771873 | ||
| Disruption of neocortical histone H3 homeostasis by soluble Aβ: implications for Alzheimer's disease | Q46946698 | ||
| Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex | Q48162019 | ||
| DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain | Q48521070 | ||
| Cardioprotection by intermittent fasting in rats | Q48703491 | ||
| S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. | Q50974734 | ||
| REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. | Q52049234 | ||
| Genetics and epigenetics of Parkinson's disease. | Q53375184 | ||
| Epilepsia. Ketogenic diet and treatments. Introduction/perspectives | Q82804304 | ||
| Epigenetic mechanisms in Alzheimer's disease | Q83829640 | ||
| Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update | Q22252904 | ||
| EUKARYOTIC CYTOSINE METHYLTRANSFERASES | Q22255656 | ||
| Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity | Q24301946 | ||
| H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions | Q24317641 | ||
| Epigenetic differences arise during the lifetime of monozygotic twins | Q24531005 | ||
| Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine | Q24562104 | ||
| Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys | Q24568041 | ||
| DNA methylation and memory formation | Q24596970 | ||
| A decade of exploring the cancer epigenome - biological and translational implications | Q24614467 | ||
| Distinct DNA methylation changes highly correlated with chronological age in the human brain | Q24616264 | ||
| Epigenetic mechanisms in drug addiction | Q24645709 | ||
| Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy | Q24650174 | ||
| Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities | Q27023811 | ||
| The language of covalent histone modifications | Q27860931 | ||
| The role of chromatin during transcription | Q27860995 | ||
| REST and stress resistance in ageing and Alzheimer's disease | Q28236857 | ||
| Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death | Q28260806 | ||
| Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy | Q28270060 | ||
| Genomic DNA methylation: the mark and its mediators | Q28290773 | ||
| Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease | Q28307422 | ||
| Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes | Q28511419 | ||
| Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene | Q28579417 | ||
| Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli | Q28591800 | ||
| NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases | Q28650457 | ||
| Epigenetic regulation in psychiatric disorders | Q29616296 | ||
| Functions of site-specific histone acetylation and deacetylation | Q29617894 | ||
| Tau-mediated neurodegeneration in Alzheimer's disease and related disorders | Q29618148 | ||
| A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease. | Q30365907 | ||
| Deep sequencing reveals increased DNA methylation in chronic rat epilepsy | Q30557209 | ||
| DNA methylation of BDNF as a biomarker of early-life adversity | Q30653771 | ||
| Molecular neuropathology of human mesial temporal lobe epilepsy | Q33748790 | ||
| Fasting followed by vegetarian diet in patients with rheumatoid arthritis: a systematic review | Q33938371 | ||
| Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy | Q34030634 | ||
| Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens | Q34086476 | ||
| Altered histone acetylation is associated with age-dependent memory impairment in mice. | Q34114011 | ||
| Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis | Q34134534 | ||
| Ketone bodies as signaling metabolites. | Q34252732 | ||
| Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor | Q34316485 | ||
| The many faces of REST oversee epigenetic programming of neuronal genes | Q34449364 | ||
| The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year. | Q34497520 | ||
| Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet | Q34542879 | ||
| Brain function and chromatin plasticity | Q34620395 | ||
| Epigenetic mechanisms in cognition | Q34630009 | ||
| Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. | Q34660005 | ||
| Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases | Q34685028 | ||
| Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease | Q34734276 | ||
| Molecular insights into Parkinson's disease | Q34988753 | ||
| Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention | Q35007040 | ||
| The methionine-homocysteine cycle and its effects on cognitive diseases | Q35075332 | ||
| Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies | Q35177463 | ||
| Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neurons | Q35676840 | ||
| Intermittent fasting modulation of the diabetic syndrome in streptozotocin-injected rats | Q35691789 | ||
| Histone variants, nucleosome assembly and epigenetic inheritance | Q35818464 | ||
| Epigenetic mechanisms in memory formation. | Q36011654 | ||
| Neurotrophin signalling in health and disease | Q36367776 | ||
| Improvement in coronary heart disease risk factors during an intermittent fasting/calorie restriction regimen: Relationship to adipokine modulations | Q36444966 | ||
| Epigenetics and epilepsy. | Q36493159 | ||
| A hundred years of Alzheimer's disease research | Q36610336 | ||
| Epigenetics-Based Therapeutics for Neurodegenerative Disorders | Q36697733 | ||
| Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. | Q36793926 | ||
| Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. | Q36838757 | ||
| Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons | Q36965800 | ||
| On the enzymatic properties of Dnmt1: specificity, processivity, mechanism of linear diffusion and allosteric regulation of the enzyme | Q36983640 | ||
| Mediterranean diet and mild cognitive impairment | Q37121952 | ||
| Epigenetic mechanisms mediating the long-term effects of maternal care on development. | Q37145451 | ||
| The cell biology of DNA methylation in mammals. | Q37245027 | ||
| Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial | Q37323187 | ||
| Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases | Q37332243 | ||
| Decoding the epigenetic language of neuronal plasticity | Q37358580 | ||
| Expression of dense-core vesicles and of their exocytosis are governed by the repressive transcription factor NRSF/REST. | Q37374910 | ||
| Transcriptional and epigenetic functions of histone variant H2A.Z. | Q37398592 | ||
| The emerging field of neuroepigenetics | Q37425986 | ||
| Epigenetic regulation in the pathophysiology of Alzheimer's disease | Q37680418 | ||
| Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease | Q37772498 | ||
| Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. | Q37790861 | ||
| Epigenetic alterations associated with cellular senescence: a barrier against tumorigenesis or a red carpet for cancer? | Q37938601 | ||
| Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model. | Q37980886 | ||
| Epigenetic regulation of memory formation and maintenance. | Q38074367 | ||
| Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy | Q38108084 | ||
| Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? | Q38109784 | ||
| Interpreting the language of histone and DNA modifications | Q38196193 | ||
| Rationale for using intermittent calorie restriction as a dietary treatment for drug resistant epilepsy | Q38198419 | ||
| The potential of epigenetic therapies in neurodegenerative diseases | Q38234971 | ||
| Alzheimer's disease and epigenetic diet. | Q38257632 | ||
| The epigenetic basis of memory formation and storage | Q38269734 | ||
| The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer's disease | Q38278645 | ||
| The emerging role of 5-hydroxymethylcytosine in neurodegenerative diseases | Q38299777 | ||
| Naming from definition, semantic relevance and feature type: the effects of aging and Alzheimer's disease. | Q38499254 | ||
| Identification of the REST regulon reveals extensive transposable element-mediated binding site duplication | Q38517920 | ||
| Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition | Q39676713 | ||
| Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation | Q39802734 | ||
| Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models | Q39924456 | ||
| gamma-Secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. | Q40081843 | ||
| Influence of threonine metabolism on S-adenosylmethionine and histone methylation | Q40648296 | ||
| REST/NRSF-mediated intrinsic homeostasis protects neuronal networks from hyperexcitability. | Q41825327 | ||
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 58 | |
| P577 | publication date | 2015-02-27 | |
| P1433 | published in | Frontiers in Cellular Neuroscience | Q2131509 |
| P1476 | title | Epigenetic mechanisms in neurological and neurodegenerative diseases | |
| P478 | volume | 9 |
| Q39540210 | A systems biology-led insight into the role of the proteome in neurodegenerative diseases |
| Q47829315 | Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases. |
| Q64764558 | Alpha-synuclein at the nexus of genes and environment: the impact of environmental enrichment and stress on brain health and disease |
| Q92603838 | Alzheimer's disease: pathogenesis, diagnostics, and therapeutics |
| Q43063864 | Anticonvulsant Effect of Time-Restricted Feeding in a Pilocarpine-Induced Seizure Model: Metabolic and Epigenetic Implications |
| Q92926139 | Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models |
| Q37611722 | Contribution of Neuroepigenetics to Huntington's Disease. |
| Q90632433 | DNA Methylation in Neurodegenerative and Cerebrovascular Disorders |
| Q38762350 | Dad's Snoring May Have Left Molecular Scars in Your DNA: the Emerging Role of Epigenetics in Sleep Disorders |
| Q38711908 | Editing the genome of hiPSC with CRISPR/Cas9: disease models |
| Q42259466 | Effect of methotrexate/vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity |
| Q64071921 | Epigenetic Analysis in Human Neurons: Considerations for Disease Modeling in PD |
| Q38993596 | Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics. |
| Q38686112 | Exercise and Nutritional Benefits in PD: Rodent Models and Clinical Settings |
| Q28069705 | Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases |
| Q37683341 | Lysine Acetylation and Deacetylation in Brain Development and Neuropathies |
| Q26747013 | MeCP2 and the enigmatic organization of brain chromatin. Implications for depression and cocaine addiction |
| Q52369540 | Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin. |
| Q60946456 | NRSF and Its Epigenetic Effectors: New Treatments for Neurological Disease |
| Q39076065 | Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease |
| Q47290734 | Neurodegenerative Disease Proteinopathies Are Connected to Distinct Histone Post-translational Modification Landscapes. |
| Q48024631 | Nutritional habits, risk, and progression of Parkinson disease |
| Q37065788 | Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response |
| Q58555658 | Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases |
| Q98726168 | Poly (I:C) Exposure in Early Life Alters Methylation of DNA and Acetylation of Histone at Synaptic Plasticity Gene Promoter in Developing Rat Brain Leading to Memory Impairment |
| Q92354306 | Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World |
| Q90640897 | Protective effects of histone deacetylase inhibition by Scriptaid on brain injury in neonatal rat models of cerebral ischemia and hypoxia |
| Q94601317 | QSAR-driven rational design of novel DNA methyltransferase 1 inhibitors |
| Q38820807 | Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics |
| Q42926328 | Reshaping the Chromatin and Epigenetic Landscapes with Quantitative Mass Spectrometry |
| Q37699534 | Stress and the Emerging Roles of Chromatin Remodeling in Signal Integration and Stable Transmission of Reversible Phenotypes. |
| Q39313679 | The emerging field of epigenetics in neurodegeneration and neuroprotection |
| Q37369669 | Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses |
| Q39311565 | β-Hydroxybutyrate: A Signaling Metabolite. |
Search more.